6-KThe Wire
Brainsway Ltd. files 6-K
Filed Mar 26, 2026 · 3mo ago · Accession 0001171843-26-001925
Plain English
Brainsway Ltd. announced it completed an additional $6 million milestone-based investment in Neurolief Ltd. following the FDA approval of Neurolief's Proliv™Rx System for Major Depressive Disorder (MDD).
Filing details
- Company
- Brainsway Ltd.
- Ticker
- BWAY
- CIK
- 1505065
- Form type
- 6-K
- Filing date
- Mar 26, 2026
- Report date
- Mar 26, 2026
- Document
- f6k_032526.htm
- Size
- 16 KB